Literature DB >> 22577091

Molecular mechanisms of prolactin and its receptor.

Charles L Brooks1.   

Abstract

Prolactin and the prolactin receptors are members of a family of hormone/receptor pairs which include GH, erythropoietin, and other ligand/receptor pairs. The mechanisms of these ligand/receptor pairs have broad similarities, including general structures, ligand/receptor stoichiometries, and activation of several common signaling pathways. But significant variations in the structural and mechanistic details are present among these hormones and their type 1 receptors. The prolactin receptor is particularly interesting because it can be activated by three sequence-diverse human hormones: prolactin, GH, and placental lactogen. This system offers a unique opportunity to compare the detailed molecular mechanisms of these related hormone/receptor pairs. This review critically evaluates selected literature that informs these mechanisms, compares the mechanisms of the three lactogenic hormones, compares the mechanism with those of other class 1 ligand/receptor pairs, and identifies information that will be required to resolve mechanistic ambiguities. The literature describes distinct mechanistic differences between the three lactogenic hormones and their interaction with the prolactin receptor and describes more significant differences between the mechanisms by which other related ligands interact with and activate their receptors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22577091      PMCID: PMC3410225          DOI: 10.1210/er.2011-1040

Source DB:  PubMed          Journal:  Endocr Rev        ISSN: 0163-769X            Impact factor:   19.871


  156 in total

1.  A dominant-negative mutation of the growth hormone receptor causes familial short stature.

Authors:  R M Ayling; R Ross; P Towner; S Von Laue; J Finidori; S Moutoussamy; C R Buchanan; P E Clayton; M R Norman
Journal:  Nat Genet       Date:  1997-05       Impact factor: 38.330

2.  N-glycosylation of the prolactin receptor is not required for activation of gene transcription but is crucial for its cell surface targeting.

Authors:  H Buteau; A Pezet; F Ferrag; M Perrot-Applanat; P A Kelly; M Edery
Journal:  Mol Endocrinol       Date:  1998-04

3.  Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11.

Authors:  Z Z Hu; J Meng; M L Dufau
Journal:  J Biol Chem       Date:  2001-08-22       Impact factor: 5.157

Review 4.  The role of prolactin in mammary carcinoma.

Authors:  Charles V Clevenger; Priscilla A Furth; Susan E Hankinson; Linda A Schuler
Journal:  Endocr Rev       Date:  2003-02       Impact factor: 19.871

5.  Studies on prolactin. Selective reduction of the disulfide bonds of the ovine hormone.

Authors:  B A Doneen; T A Bewley; C H Li
Journal:  Biochemistry       Date:  1979-10-30       Impact factor: 3.162

6.  Molecular evolution of prolactin in primates.

Authors:  O Caryl Wallis; Akofa O Mac-Kwashie; Georgia Makri; Michael Wallis
Journal:  J Mol Evol       Date:  2005-05       Impact factor: 2.395

Review 7.  Prolactin as an autocrine/paracrine growth factor in human cancer.

Authors:  Nira Ben-Jonathan; Karen Liby; Molly McFarland; Michael Zinger
Journal:  Trends Endocrinol Metab       Date:  2002-08       Impact factor: 12.015

Review 8.  S179D prolactin: antagonistic agony!

Authors:  Ameae M Walker
Journal:  Mol Cell Endocrinol       Date:  2007-06-28       Impact factor: 4.102

9.  Structural and thermodynamic bases for the design of pure prolactin receptor antagonists: X-ray structure of Del1-9-G129R-hPRL.

Authors:  Jean-Baptiste Jomain; Estelle Tallet; Isabelle Broutin; Sylviane Hoos; Jan van Agthoven; Arnaud Ducruix; Paul A Kelly; Birthe B Kragelund; Patrick England; Vincent Goffin
Journal:  J Biol Chem       Date:  2007-09-04       Impact factor: 5.157

10.  A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription.

Authors:  J J Lebrun; S Ali; V Goffin; A Ullrich; P A Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1995-04-25       Impact factor: 11.205

View more
  31 in total

1.  Mycotoxin ochratoxin A disrupts renal development via a miR-731/prolactin receptor axis in zebrafish.

Authors:  Ting-Shuan Wu; Jiann-Jou Yang; Yan-Wei Wang; Feng-Yih Yu; Biing-Hui Liu
Journal:  Toxicol Res (Camb)       Date:  2016-01-04       Impact factor: 3.524

Review 2.  New insights in prolactin: pathological implications.

Authors:  Valérie Bernard; Jacques Young; Philippe Chanson; Nadine Binart
Journal:  Nat Rev Endocrinol       Date:  2015-03-17       Impact factor: 43.330

3.  The thyroid axis, prolactin, and exercise in humans.

Authors:  Anthony C Hackney; Ayoub Saeidi
Journal:  Curr Opin Endocr Metab Res       Date:  2019-07-05

4.  Prolactin Signaling Stimulates Invasion via Na(+)/H(+) Exchanger NHE1 in T47D Human Breast Cancer Cells.

Authors:  Elena Pedraz-Cuesta; Jacob Fredsted; Helene H Jensen; Annika Bornebusch; Lene N Nejsum; Birthe B Kragelund; Stine F Pedersen
Journal:  Mol Endocrinol       Date:  2016-05-13

5.  Pancreatic prolactin receptor signaling regulates maternal glucose homeostasis.

Authors:  Jackson Nteeba; Kaiyu Kubota; Wenfang Wang; Hao Zhu; Jay Vivian; Guoli Dai; Michael Soares
Journal:  J Endocrinol       Date:  2019-02-01       Impact factor: 4.286

Review 6.  Biomarkers in uterine leiomyoma.

Authors:  Gary Levy; Micah J Hill; Torie C Plowden; William H Catherino; Alicia Y Armstrong
Journal:  Fertil Steril       Date:  2012-11-29       Impact factor: 7.329

7.  Zinc Finger Homeodomain Factor Zfhx3 Is Essential for Mammary Lactogenic Differentiation by Maintaining Prolactin Signaling Activity.

Authors:  Dan Zhao; Gui Ma; Xiaolin Zhang; Yuan He; Mei Li; Xueying Han; Liya Fu; Xue-Yuan Dong; Tamas Nagy; Qiang Zhao; Li Fu; Jin-Tang Dong
Journal:  J Biol Chem       Date:  2016-04-20       Impact factor: 5.157

Review 8.  β-Cell adaptation in pregnancy.

Authors:  L Baeyens; S Hindi; R L Sorenson; M S German
Journal:  Diabetes Obes Metab       Date:  2016-09       Impact factor: 6.577

9.  Defective prolactin signaling impairs pancreatic β-cell development during the perinatal period.

Authors:  Julien Auffret; Michael Freemark; Nadège Carré; Yves Mathieu; Cécile Tourrel-Cuzin; Marc Lombès; Jamileh Movassat; Nadine Binart
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-09-24       Impact factor: 4.310

10.  STAT5 and prolactin participate in a positive autocrine feedback loop that promotes angiogenesis.

Authors:  Xinhai Yang; Kristy Meyer; Andreas Friedl
Journal:  J Biol Chem       Date:  2013-06-02       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.